 UPPSALA, Sweden, July 21, 2021 GLOBE NEWSWIRE -- Olink Holding AB publ Nasdaq: OLK today announced that the UK Biobank Pharma Proteomics Project UKB-PPP Consortium has decided to expand the ongoing proteomics study of 53,000 participants to the new Olink Explore 3072 platform, providing access to Olink s expanded library of approximately 3,000 carefully curated and validated assays. 